Physician profile
Mark A Milton
NPI 1922023951
$5,230.79
in general payments reported to CMS, 2019-2025
17 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2021: $1,483 · 2022: $1,228 · 2023: $791 · 2024: $849 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,798.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,537.62 | 2021-2024 | Pulseselect, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $1,179.46 | 2021-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Viewmate |
| Biosense Webster, INC. | $622.52 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Medtronic Vascular, INC. | $565.65 | 2019 | |
| Boston Scientific Corporation | $378.52 | 2022-2025 | Watchman Flx, Labsystem Pro |
| Impulse Dynamics (USA) INC. | $272.18 | 2023-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $140.90 | 2022-2024 | |
| Pfizer INC. | $133.58 | 2022-2025 | |
| Atricure, INC. | $90.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $83.78 | 2022-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $74.29 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $47.62 | 2023 | Andexxa, Farxiga, Brilinta |
| Bayer Healthcare Pharmaceuticals INC. | $42.17 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.67 | 2022 | |
| Teleflex LLC | $15.66 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.87 | 2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Milton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.